Next Article in Journal
The Spectrum of Esophagitis in Patients Living with HIV—A Scoping Review
Previous Article in Journal
Continuous Versus Intermittent Infusion of Beta-Lactam Antibiotics: Where Do We Stand Today? A Narrative Review
 
 
GERMS is published by MDPI from Volume 25 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum S.R.L..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Emerging Role of Pseudomonas aeruginosa in Diarrhea: Where We Stand

by
Mansoor Khaledi
1,
Ahdiyeh Saghabashi
2 and
Hossein Ghahramanpour
3,*
1
Department of Microbiology and Immunology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
2
Department of Microbiology, Faculty of Sciences, Agriculture and Modern Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran
3
Department of Bacteriology, Faculty of medical sciences, Tarbiat Modares University, Tehran, Iran
*
Author to whom correspondence should be addressed.
GERMS 2024, 14(2), 179-188; https://doi.org/10.18683/germs.2024.1429
Submission received: 22 February 2024 / Revised: 11 June 2024 / Accepted: 12 June 2024 / Published: 30 June 2024

Abstract

Although Pseudomonas aeruginosa (PA) hasn’t been considered as a recognized agent of diarrhea, this organism is able to cause community-acquired diarrhea accompanied by fever and sepsis, as well as antibiotic-associated diarrhea (AAD). Antibiotic resistance rates in stool isolates of PA are generally lower compared to other infection sites, but in patients with AAD, there are reports of resistance to most of the antibiotic classes in these isolates. PA, along with other opportunistic pathogens like Clostridioides difficile, can cause AAD. Therefore, it is suggested to examine stool samples of patients with predisposing factors such as intensive care unit (ICU) admission and long-time antibiotic treatment, especially with cephalosporins, for both C. difficile and PA.
Keywords: emerging; Pseudomonas aeruginosa; diarrhea emerging; Pseudomonas aeruginosa; diarrhea

Share and Cite

MDPI and ACS Style

Khaledi, M.; Saghabashi, A.; Ghahramanpour, H. The Emerging Role of Pseudomonas aeruginosa in Diarrhea: Where We Stand. GERMS 2024, 14, 179-188. https://doi.org/10.18683/germs.2024.1429

AMA Style

Khaledi M, Saghabashi A, Ghahramanpour H. The Emerging Role of Pseudomonas aeruginosa in Diarrhea: Where We Stand. GERMS. 2024; 14(2):179-188. https://doi.org/10.18683/germs.2024.1429

Chicago/Turabian Style

Khaledi, Mansoor, Ahdiyeh Saghabashi, and Hossein Ghahramanpour. 2024. "The Emerging Role of Pseudomonas aeruginosa in Diarrhea: Where We Stand" GERMS 14, no. 2: 179-188. https://doi.org/10.18683/germs.2024.1429

APA Style

Khaledi, M., Saghabashi, A., & Ghahramanpour, H. (2024). The Emerging Role of Pseudomonas aeruginosa in Diarrhea: Where We Stand. GERMS, 14(2), 179-188. https://doi.org/10.18683/germs.2024.1429

Article Metrics

Back to TopTop